Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent
Equine athletes are dependent on the production of ATP to run, jump or pull
Regulatory and safety status: Its currently classified as FDA Category 1, meaning sermorelin has met the FDAs safety standards for human use, and a clinician can prescribe it to you
Dont wait any longer to start your journey to optimal health and beauty.
In addition to the visual rebrand, we worked on several product photoshoots and video content
The table below illustrates the general pattern reported, not a prescription